Pheochromocytoma and Paraganglioma—Health Professional Version
Pheochromocytomas and extra-adrenal paragangliomas are rare tumors arising from neural crest tissue that develops into sympathetic and parasympathetic paraganglia throughout the body. Find evidence-based information on pheochromocytoma and paraganglioma treatment, research, and genetics.
Pheochromocytoma and Paraganglioma Treatment
-
Pheochromocytoma and Paraganglioma Treatment (PDQ®)
Get detailed information on pheochromocytoma and paraganglioma treatment, including surgery and treatment for metastatic disease, in this summary for clinicians.
-
Childhood Pheochromocytoma and Paraganglioma Treatment (PDQ®)
Get detailed information on pediatric pheochromocytoma and paraganglioma, including incidence, genetic factors, molecular features, diagnosis, and treatment, in this summary for clinicians.
-
Late Effects of Treatment for Childhood Cancer (PDQ®)
Learn about subsequent neoplasms and the cardiovascular, cognitive, psychosocial, digestive, endocrine, immune, musculoskeletal, reproductive, and urinary late effects of pediatric cancer treatment in this expert-reviewed summary.
Genetics
-
Cancer Genetics Overview (PDQ®)
Get information about genetic counseling, familial cancer syndromes, genomic sequencing, germline and somatic testing, ethical and legal issues and more in this summary for clinicians.
-
Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)
Genetics of Endocrine and Neuroendocrine Neoplasias discusses inherited syndromes MEN1, MEN2, MEN4, familial pheochromocytoma/paraganglioma, Carney-Stratakis syndrome, and familial nonmedullary thyroid cancer. Learn more in this clinician summary.
-
Multiple Endocrine Neoplasia Type 2 (MEN2)(PDQ®)
Multiple endocrine neoplasia type 2 (MEN2) is a hereditary syndrome associated with the RET gene. Learn about MEN2’s clinical features and management.
-
Cancer Genetics Risk Assessment and Counseling (PDQ®)
Get more information including the ethical, legal, and social implications of genetic testing in this summary for clinicians.
Supportive & Palliative Care
-
Cancer Pain (PDQ®)
Get comprehensive, practical information on the screening, assessment, and management of cancer-related pain in this summary for clinicians.
-
Nausea and Vomiting Related to Cancer Treatment (PDQ®)
Get detailed information about prevention and treatment approaches for treatment-related nausea and vomiting in this summary for clinicians.
-
Nutrition in Cancer Care (PDQ®)
Get information about strategies to screen, assess, and treat nutritional problems, including through diet and supplements, in this clinician summary.
-
Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)
Planning the transition to end-of-life care in advanced cancer involves challenging decisions. Get information about strategies to improve patient-oncologist communication and decision making in this clinician summary.
-
Last Days of Life (PDQ®)
The last days of life for patients with cancer involves managing end-of-life (EOL) care issues for a wide range of possible symptoms and ethical dilemmas. Get detailed information about EOL issues and the role of the oncologist in this clinician summary.
-
Supportive and Palliative Care—PDQ® Cancer Information Summaries
The supportive and palliative care summaries provide descriptions of the pathophysiology and treatment of common physical and psychosocial complications of cancer and its treatment, such as pain, fatigue, and nausea/vomiting.